# A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

> clinical trial · VERIFIED · 2026-07-17

Status: RECRUITING · Sponsor: Incyte Corporation · Condition: CRC (Colorectal Cancer)

- Company: Incyte Corporation
- Sector: CRC (Colorectal Cancer)
- Primary source: https://clinicaltrials.gov/study/NCT07284849

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.